Interaction of Hb adana (HBA2: c.179G>A) with deletional and nondeletional α(+)-thalassemia mutations: diverse hematological and clinical features

Hemoglobin. 2013;37(3):297-305. doi: 10.3109/03630269.2013.775149. Epub 2013 Apr 25.

Abstract

We describe 27 cases of mild-to-severe α-thalassemia (α-thal) syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp, GGC>GAC (α2)] with deletional and nondeletional α(+)-thal mutations in Indonesian patients. Hematological profiles and clinical manifestations of all patients were assessed by routine procedures. The genotypes were generated by a multiplex-polymerase chain reaction (m-PCR), PCR-RFLP (restriction fragment length polymorphism)-based method, and DNA sequencing. The α-thal patients who had Hb Adana in combination with the 3.7 kb deletion mostly have mild-to-moderate anemia. In contrast, patients who were compound heterozygotes for Hb Adana and nondeletional mutations, generally showed a more severe anemia and it mostly presented in childhood. Thus, accurate diagnosis of α-thal disorders is not only important for future management of these patients but also for providing proper genetic counseling to the family.

MeSH terms

  • Adolescent
  • Adult
  • Base Sequence
  • Child
  • Child, Preschool
  • Epistasis, Genetic
  • Female
  • Genotype
  • Hemoglobins, Abnormal / genetics*
  • Heterozygote
  • Homozygote
  • Humans
  • Infant
  • Male
  • Molecular Sequence Data
  • Multiplex Polymerase Chain Reaction
  • Mutation*
  • Phenotype
  • Sequence Deletion
  • Severity of Illness Index
  • alpha-Thalassemia / genetics*
  • alpha-Thalassemia / physiopathology

Substances

  • Hemoglobins, Abnormal
  • hemoglobin Adana